Published in Drug Week, September 6th, 2002
The FDA concluded that MGP's drug is safe and effective for use as recommended in the labeling and bioequivalent and, therefore, therapeutically equivalent to the brand drug Pediapred Oral Solution, 5 mg /5 mL marketed by Celltech Pharmaceuticals, Inc.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.